Test-retest stability of the Repeatable Battery for the Assessment of Neuropsychological Status in schizophrenia

Christopher M. Wilk, James M. Gold, John J. Bartko, Faith Dickerson, Wayne S. Fenton, Michael Knable, Christopher Randolph, Robert W. Buchanan

Research output: Contribution to journalArticle

Abstract

Objective: The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) was designed as a cognitive screening test, providing both a total scale score and five specific cognitive ability index scores. This study examined the test-retest stability of the RBANS in individual patients with schizophrenia relative to a healthy comparison group. Method: A total of 181 patients with schizophrenia or schizoaffective disorder were recruited from three clinical settings. Healthy comparison subjects were recruited as part of the RBANS standardization. Participants were administered one form of the RBANS on one occasion and another form at a later date, with intervals ranging from 1 to 134 days. Results: Intraclass correlation coefficients for the RBANS total scale were 0.84 for the patients with schizophrenia and 0.77 for the healthy comparison subjects. Confidence intervals and percentile data for the total scale change scores were similar for both groups. Conclusions: The RBANS demonstrated reasonable intraclass correlation coefficient test-retest reliability for both schizophrenia patients and healthy comparison subjects. Confidence intervals are comparable to those previously published for the WAIS-R and Wechsler Memory Scale-Revised, suggesting that retest measurement error is not dramatically increased in the RBANS, despite the brevity of the test. These data may serve as an informative guide for using the RBANS to evaluate neuropsychological change on the level of the individual subject.

Original languageEnglish (US)
Pages (from-to)838-844
Number of pages7
JournalAmerican Journal of Psychiatry
Volume159
Issue number5
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Schizophrenia
Healthy Volunteers
Confidence Intervals
Wechsler Scales
Aptitude
Reproducibility of Results
Psychotic Disorders

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Wilk, C. M., Gold, J. M., Bartko, J. J., Dickerson, F., Fenton, W. S., Knable, M., ... Buchanan, R. W. (2002). Test-retest stability of the Repeatable Battery for the Assessment of Neuropsychological Status in schizophrenia. American Journal of Psychiatry, 159(5), 838-844. https://doi.org/10.1176/appi.ajp.159.5.838

Test-retest stability of the Repeatable Battery for the Assessment of Neuropsychological Status in schizophrenia. / Wilk, Christopher M.; Gold, James M.; Bartko, John J.; Dickerson, Faith; Fenton, Wayne S.; Knable, Michael; Randolph, Christopher; Buchanan, Robert W.

In: American Journal of Psychiatry, Vol. 159, No. 5, 2002, p. 838-844.

Research output: Contribution to journalArticle

Wilk, CM, Gold, JM, Bartko, JJ, Dickerson, F, Fenton, WS, Knable, M, Randolph, C & Buchanan, RW 2002, 'Test-retest stability of the Repeatable Battery for the Assessment of Neuropsychological Status in schizophrenia', American Journal of Psychiatry, vol. 159, no. 5, pp. 838-844. https://doi.org/10.1176/appi.ajp.159.5.838
Wilk, Christopher M. ; Gold, James M. ; Bartko, John J. ; Dickerson, Faith ; Fenton, Wayne S. ; Knable, Michael ; Randolph, Christopher ; Buchanan, Robert W. / Test-retest stability of the Repeatable Battery for the Assessment of Neuropsychological Status in schizophrenia. In: American Journal of Psychiatry. 2002 ; Vol. 159, No. 5. pp. 838-844.
@article{4e9a9f50c749435aa811bc3c6b69398d,
title = "Test-retest stability of the Repeatable Battery for the Assessment of Neuropsychological Status in schizophrenia",
abstract = "Objective: The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) was designed as a cognitive screening test, providing both a total scale score and five specific cognitive ability index scores. This study examined the test-retest stability of the RBANS in individual patients with schizophrenia relative to a healthy comparison group. Method: A total of 181 patients with schizophrenia or schizoaffective disorder were recruited from three clinical settings. Healthy comparison subjects were recruited as part of the RBANS standardization. Participants were administered one form of the RBANS on one occasion and another form at a later date, with intervals ranging from 1 to 134 days. Results: Intraclass correlation coefficients for the RBANS total scale were 0.84 for the patients with schizophrenia and 0.77 for the healthy comparison subjects. Confidence intervals and percentile data for the total scale change scores were similar for both groups. Conclusions: The RBANS demonstrated reasonable intraclass correlation coefficient test-retest reliability for both schizophrenia patients and healthy comparison subjects. Confidence intervals are comparable to those previously published for the WAIS-R and Wechsler Memory Scale-Revised, suggesting that retest measurement error is not dramatically increased in the RBANS, despite the brevity of the test. These data may serve as an informative guide for using the RBANS to evaluate neuropsychological change on the level of the individual subject.",
author = "Wilk, {Christopher M.} and Gold, {James M.} and Bartko, {John J.} and Faith Dickerson and Fenton, {Wayne S.} and Michael Knable and Christopher Randolph and Buchanan, {Robert W.}",
year = "2002",
doi = "10.1176/appi.ajp.159.5.838",
language = "English (US)",
volume = "159",
pages = "838--844",
journal = "American Journal of Psychiatry",
issn = "0002-953X",
publisher = "American Psychiatric Association",
number = "5",

}

TY - JOUR

T1 - Test-retest stability of the Repeatable Battery for the Assessment of Neuropsychological Status in schizophrenia

AU - Wilk, Christopher M.

AU - Gold, James M.

AU - Bartko, John J.

AU - Dickerson, Faith

AU - Fenton, Wayne S.

AU - Knable, Michael

AU - Randolph, Christopher

AU - Buchanan, Robert W.

PY - 2002

Y1 - 2002

N2 - Objective: The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) was designed as a cognitive screening test, providing both a total scale score and five specific cognitive ability index scores. This study examined the test-retest stability of the RBANS in individual patients with schizophrenia relative to a healthy comparison group. Method: A total of 181 patients with schizophrenia or schizoaffective disorder were recruited from three clinical settings. Healthy comparison subjects were recruited as part of the RBANS standardization. Participants were administered one form of the RBANS on one occasion and another form at a later date, with intervals ranging from 1 to 134 days. Results: Intraclass correlation coefficients for the RBANS total scale were 0.84 for the patients with schizophrenia and 0.77 for the healthy comparison subjects. Confidence intervals and percentile data for the total scale change scores were similar for both groups. Conclusions: The RBANS demonstrated reasonable intraclass correlation coefficient test-retest reliability for both schizophrenia patients and healthy comparison subjects. Confidence intervals are comparable to those previously published for the WAIS-R and Wechsler Memory Scale-Revised, suggesting that retest measurement error is not dramatically increased in the RBANS, despite the brevity of the test. These data may serve as an informative guide for using the RBANS to evaluate neuropsychological change on the level of the individual subject.

AB - Objective: The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) was designed as a cognitive screening test, providing both a total scale score and five specific cognitive ability index scores. This study examined the test-retest stability of the RBANS in individual patients with schizophrenia relative to a healthy comparison group. Method: A total of 181 patients with schizophrenia or schizoaffective disorder were recruited from three clinical settings. Healthy comparison subjects were recruited as part of the RBANS standardization. Participants were administered one form of the RBANS on one occasion and another form at a later date, with intervals ranging from 1 to 134 days. Results: Intraclass correlation coefficients for the RBANS total scale were 0.84 for the patients with schizophrenia and 0.77 for the healthy comparison subjects. Confidence intervals and percentile data for the total scale change scores were similar for both groups. Conclusions: The RBANS demonstrated reasonable intraclass correlation coefficient test-retest reliability for both schizophrenia patients and healthy comparison subjects. Confidence intervals are comparable to those previously published for the WAIS-R and Wechsler Memory Scale-Revised, suggesting that retest measurement error is not dramatically increased in the RBANS, despite the brevity of the test. These data may serve as an informative guide for using the RBANS to evaluate neuropsychological change on the level of the individual subject.

UR - http://www.scopus.com/inward/record.url?scp=0036235184&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036235184&partnerID=8YFLogxK

U2 - 10.1176/appi.ajp.159.5.838

DO - 10.1176/appi.ajp.159.5.838

M3 - Article

C2 - 11986139

AN - SCOPUS:0036235184

VL - 159

SP - 838

EP - 844

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

SN - 0002-953X

IS - 5

ER -